Chronic diseases globally is raising day by day because of which more of the people get affected and their organs get infected which leads to organ failure if early stage intervention and precaution is not taken by the patient. Government, private and NGO should conduct informative and knowledgeable seminars and advertisements to spread the awareness about organ transplantation. Attention to organ donation can help take care of the demand for the quantity of required transplantation. Many individuals are involved in the cause for organ transplantation, but only few people donate organs. Associations need to spread knowledge and information about the advantages of organ transplantation to take care of the demand for a benefactor organ and decrease the death rate. Transplant diagnostics market demand is growing and use is increasing that have attracted many manufacturers to come with innovative products.
How Big is the Global Transplant Diagnostics Market?
The Transplant Diagnostics Market is expected to be around US$ 6.20 billion by 2028 at a CAGR of 7% in the given forecast period.
The major driving factors of Transplant Diagnostics Market are as follows:
The restraining factors of Transplant Diagnostics Market are as follows:
The Transplant Diagnostics Market is segmented on the lines of its product/service, technology, application, end user and regional. Based on product/service segmentation it covers Instruments, Reagents and Consumables, Software and Services. Based on technology segmentation it covers Molecular Assay, Non-molecular Assay. Based on application segmentation it covers Research Applications, Diagnostic Applications. Based on end user segmentation it covers Commercial Service Providers, Hospitals and Transplant Centers, Research Laboratories and Academic Institutes. The Transplant Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Transplant Diagnostics Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Transplant Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets onTransplant Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and GenDx (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Transplant Diagnostics Market has been segmented as below:
By Application Analysis:
By Product/ Service Analysis
By Technology Analysis:
By End User Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Transplant Diagnostics Market .
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Transplant Diagnostics Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Semi Automated Clinical Analyzers market
Sepsis Detection Device Market
Single Tooth Implants and Dental Bridges Market
Single-Photon Emission Computed Tomography market
Single-use negative pressure wound therapy (NPWT) devices marke
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Healthcare Expenditure Patterns
2.2.2 Rapid Growth in Geriatric Population
2.2.3 Rising Incidence and Prevalence of Cancer
2.2.4 Growing Burden of Cardiovascular Diseases
2.2.5 Organ Donations and Transplantations
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
3 Executive Summary
4 Premium Insights
4.1 Global Transplant Diagnostics Market Overview
4.2 Global Transplant Diagnostic Technology Market, By Region (2020)
4.3 Global Transplant Diagnostics Product and Services Market, By Region (2022-2027)
4.4 Global Transplant Diagnostic Applications Market, By Region (2022-2027)
4.5 Global Transplant Diagnostic Market, By End User (2022-2027)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Rising Number of Solid Organ, Soft-Tissue, and Stem Cell Transplantation Procedures
5.2.1.2 Technological Advancements
5.2.1.3 Growing Public-Private Investments and Funding
5.2.1.4 Rising Incidence of Chronic and Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Cost of NGS and PCR-Based Devices
5.2.2.2 Limited Medical Reimbursements for Organ Donation and Transplantation Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Technological Shift From Serological Assays to Gene-Based Donor-Recipient Profiling
5.2.3.2 Untapped Opportunities in Emerging Markets
5.2.3.3 Increasing Public Awareness About Organ Donation and Transplantation in Developed Countries
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between Number of Organs Donated and Organs Required Annually
6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Integration of Advanced Technologies With Molecular Assay Procedures
6.3.2 Development of Biomarkers for Transplantation Procedures
6.4 Porter’s Five Forces Analysis
6.4.1 Threat of New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
7 Transplant Diagnostics Market, By Technology
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 PCR-Based Molecular Assay Technologies
7.2.1.1 Real-Time PCR
7.2.1.2 Sequence-Specific Primer-PCR (SSP-PCR)
7.2.1.3 Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
7.2.1.4 Other PCR Technologies
7.2.2 Sequencing-Based Molecular Assay Technologies
7.2.2.1 Sanger Sequencing
7.2.2.2 Next-Generation Sequencing (NGS)
7.2.2.3 Other Sequencing Technologies
7.3 Non-Molecular Assay Technologies
8 Transplant Diagnostics Market, By Products & Services
8.1 Introduction
8.2 Reagents and Consumables
8.3 Instruments
8.4 Software and Services
9 Transplant Diagnostics Market, By Application
9.1 Introduction
9.2 Diagnostic Applications
9.2.1 Infectious Disease Diagnostics
9.2.2 Histocombatibility Testing
9.2.3 Blood Profiling
9.3 Research Applications
10 Transplant Diagnostics Market, By End User
10.1 Introduction
10.2 Commercial Service Providers
10.3 Hospitals and Transplant Centers
10.4 Research Laboratories and Academic Institutes
11 Transplant Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)
12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Strategic Benchmarking
12.3.1.1 Pipeline Development and Product Commercialization
12.4 Recent Developments
12.4.1 New Product Launches, Approvals, and Product Enhancement
12.4.2 Agreements, Partnerships, and Collaborations
12.4.3 Acquisition
12.4.4 Expansion
12.4.5 Other Developments
13 Company Profiles
13.1 Introduction
13.2 Thermo Fisher Scientific Inc.
13.3 Bio-Rad Laboratories, Inc.
13.4 F. Hoffman-La Roche Limited
13.5 Qiagen N.V.
13.6 Immucor, Inc.
13.7 Biomérieux SA
13.8 Illumina, Inc.
13.9 Becton Dickinson and Company
13.10 Caredx, Inc.
13.11 Gendx
The Transplant Diagnostics Market has been segmented as below:
By Application Analysis:
By Product/ Service Analysis
By Technology Analysis:
By End User Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
